Annie Darwin's death, the evolution of tuberculosis and the need for systems epidemiology

International Journal of Epidemiology

Volumn 38, Issue 6, 2009, Pages 1425-1428

  Fenner, Lukas ^a   Egger, Matthias ^a   Gagneux, Sebastien ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

AIDS; Annie Darwin; Charles Darwin; Co evolution; Evolution; Genomics; HIV; Host; Interactions; Multi disciplinary; Pathogen; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; CHILD HEALTH; CONSANGUINEOUS MARRIAGE; DEMOGRAPHY; EDITORIAL; EVOLUTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HISTORY OF MEDICINE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MIXED INFECTION; MOLECULAR EVOLUTION; MYCOBACTERIUM TUBERCULOSIS; PATERNAL ATTITUDE; PRIORITY JOURNAL; SYSTEMS BIOLOGY; TUBERCULOSIS; TUBERCULOSIS CONTROL; BIOLOGICAL MODEL; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS;

EPIDEMIOLOGIC STUDIES; EVOLUTION, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, BIOLOGICAL; TUBERCULOSIS;

EID: 75349101447     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp367     Document Type: Editorial

References (30)

1. Kuper A. Commentary: A Darwin family concern. Int J Epidemiol 2009;38:1439-42.
2. Brittle AH. Commentary: the background and outcomes of the first cousin marriage controversy in Great Britain. Int J Epidemiol 2009;38:1453-58.
3. Darwin GH. Reprints and reflections: marriages between first cousins in England and their effects. Int J Epidemiol 2009;38:1429-39.
4. Stoltenberg C. Commentary: of the same blood. Int J Epidemiol 2009;38:1442-47.
5. Evans A. Commentary: Darwin's origin: the Irish connection. Int J Epidemiol 2009;38:1448-52.
6. Keynes R. Annie's Box: Charles Darwin, His Daughter, and Human Evolution. London: Fourth Estate Publishers, 2001.
7. Lederberg J. J. B. S. Haldane (1949) on infectious disease and evolution. Genetics 1999;153:1-3.
8. Hershberg R, Lipatov M, Small PM et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 2008;6:e311.
9. World Health Organization. WHO report 2008. Global tuberculosis control. Geneva: WHO, 2008.
10. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21.
11. Selwyn PA, Alcabes P, Hartel D et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992;327:1697-703.
12. Edmonds A, Lusiama J, Napravnik S, Kitetele F, Van Rie A, Behets F. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol 2009;38:1612-21.
13. Boulle A, Eley B. Commentary: reducing HIV-associated tuberculosis in children. Int J Epidemiol 2009;38:1621-23.
14. Iseman MD. Extensively drug-resistant Mycobacterium tuberculosis: Charles Darwin would understand. Clin Infect Dis 2007;45:1415-16.
15. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006;312: 1944-46.
16. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80.
17. Raviglione MC, Smith IM. XDR tuberculosis-implications for global public health. N Engl J Med 2007; 356:656-59.
18. Borrell S, Gagneux S. Infectiousness of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009;13: 1456-66.
19. Middelkoop K, Bekker LG, Mathema B et al. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J Infect Dis 2009;200:1207-11.
20. Caws M, Thwaites G, Stepniewska K et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006;44:3934-39.
21. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004 MMWR Morb Mortal Wkly Rep 2006;55:301-5.
22. Cowley D, Govender D, February B et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis 2008;47: 1252-59.
23. Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001;2:967-77.
24. Fellay J, Shianna KV, Ge D et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317:944-47.
25. Telenti A. Adaptation, co-evolution, and human susceptibility to HIV-1 infection. Infect Genet Evol 2005;5:327-34.
26. de Jong BC, Hill PC, Aiken A et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the Gambia. J Infect Dis 2008.
27. Caws M, Thwaites G, Dunstan S et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008;4:e1000034.
28. Thwaites G, Caws M, Chau TT et al. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol 2008;46:1363-68.
29. Comas I, Gagneux S. The past and future of tuberculosis research. PLoS Pathog 2009;5:e1000600.
30. Shanks N, Pyles RA. Evolution and medicine: the long reach of "Dr. Darwin". Philos Ethics Humanit Med 2007; 2:4.